Potentia

BiotechnologySeedTel Aviv, Israel

Latest round

Seed

Last raised

May 2026

Total raised

$0.9M

Investors

1

About Potentia

Based in Israel, and founded in 2022, Potentia Therapeutics is a biotechnology company pioneering a breakthrough Antibody-Oligonucleotide Conjugate (AOC) platform specifically engineered to treat diseases of the Peripheral Nervous System. Based in Israel, and founded in 2022, Potentia Therapeutics is a biotechnology company pioneering a breakthrough Antibody-Oligonucleotide Conjugate (AOC) platform specifically engineered to treat diseases of the Peripheral Nervous System. In May 2026, Potentia Ltd. Potentia Therapeutics develops biotechnology products for patients affected by Peripheral Nervous System disorders. Its core technology is an Antibody-Oligonucleotide Conjugate (AOC) platform that combines immunology-based targeting with short interfering RNA (siRNA) gene-silencing technology. The company’s lead program is directed toward Charcot-Marie-Tooth disease 1A (CMT1A), with the objective of restoring myelin formation and nerve function.

Who invested in Potentia

1 investor across 1 round

See all investors in Potentia

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    May 5, 2026

    Amount

    $0.9M

    Investors

    Locked

Questions about Potentia

Who invested in Potentia?

Potentia has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Potentia raised?

Potentia has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Potentia last raise money?

Potentia's most recent round on record is a Seed, in May 2026.

What does Potentia do?

Based in Israel, and founded in 2022, Potentia Therapeutics is a biotechnology company pioneering a breakthrough Antibody-Oligonucleotide Conjugate (AOC) platform specifically engineered to treat diseases of the Peripheral Nervous System.

Where is Potentia headquartered?

Potentia is headquartered in Tel Aviv, Israel.

Which VCs invest in companies like Potentia?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Potentia's stage. Their profiles are linked below.

Raising like Potentia? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.